FMO5 Antibodies

Santa Cruz Biotechnology delivers a wide array of FMO5 monoclonal antibodies for research focused on understanding FMO5 protein function and roles. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).FMO5, or flavin-containing monooxygenase 5, is involved in the metabolism of various xenobiotics and endogenous compounds, playing a crucial role in drug metabolism and detoxification processes. Expression of FMO5 is particularly significant in the liver and other tissues, where it contributes to the regulation of physiological functions and the maintenance of homeostasis. Understanding the activity and regulation of FMO5 is essential for elucidating its impact on pharmacokinetics and potential implications in drug interactions. Research utilizing FMO5 monoclonal antibodies has revealed important insights into metabolic pathways and drug processing mechanisms. Ongoing studies continue to uncover new functions of FMO5 in cellular metabolism and detoxification. Current investigations are expanding knowledge about FMO5's role in drug interactions and therapeutic responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FMO5's critical functions in drug metabolism and cellular processes.